ZBH as reported
Zimmer Biomet reported $8.41B of revenue over the trailing twelve months, +9.2% on the year before. 11 reported series are charted on this page, each one as filed.
$8.41B
Revenue, trailing twelve months · to Q1 2026 · +9.2% against the twelve months before
- Net Income
- $761M
Net Income · −17% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $1.46B
Free Cash Flow · −0.23% year on year · trailing twelve months to Q1 2026
- Op Margin
- 14%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $8.41B | +9.2% | Q1 2026 |
| Net Income | $761M | −17% | Q1 2026 |
| EPS | $3.86 | −14% | Q1 2026 |
| Gross Margin | 70% | n/a | Q1 2026 |
| Op Margin | 14% | n/a | Q1 2026 |
| Net Margin | 9.1% | n/a | Q1 2026 |
| ROE | 6.1% | n/a | Q1 2026 |
| ROA | 3.4% | n/a | Q1 2026 |
| ROIC | 4.9% | n/a | Q1 2026 |
| Free Cash Flow | $1.46B | −0.23% | Q1 2026 |
| P/E | 26.3 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Zimmer Biomet (ZBH) - Revenue & ProfitRevenue & ProfitZimmer Biomet (ZBH)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Devices
Ranks #14 of 35 by Smart Score